Literature DB >> 33594503

Mechanism and therapeutic strategies of depression after myocardial infarction.

Ying Yang1, Xuping Li1, Sixuan Chen1, Mingzhu Xiao1, Zhongqiu Liu1, Jingyan Li2, Yuanyuan Cheng3.   

Abstract

Depression resulted as an important factor associated with the myocardial infarction (MI) prognosis. Patients with MI also have a higher risk for developing depression. Although the issue of depression after MI has become a matter of clinical concern, the molecular mechanism underlying depression after MI remains unclear, whereby several strategies suggested have not got ideal effects, such as selective serotonin reuptake inhibitors. In this review, we summarized and discussed the occurrence mechanism of depression after MI, such as 5-hydroxytryptamine (5-HT) dysfunction, altered hypothalamus-pituitary-adrenal (HPA) axis function, gut microbiota imbalance, exosomal signal transduction, and inflammation. In addition, we offered a succinct overview of treatment, as well as some promising molecules especially from natural products for the treatment of depression after MI.

Entities:  

Keywords:  Depression; Inflammation; Myocardial infarction; Therapy

Year:  2021        PMID: 33594503     DOI: 10.1007/s00213-021-05784-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  122 in total

1.  On the tryptophan-serotonin metabolism in manic-depressive disorders. Changes in plasma 5-HT and 5-HIAA levels and urinary 5-HIAA excretion following oral loading of L-5HTP in patients with depression.

Authors:  T Amamoto; K Sarai
Journal:  Hiroshima J Med Sci       Date:  1976-09

2.  Goal disturbance in relation to anxiety, depression, and health-related quality of life after Myocardial Infarction.

Authors:  Sandra N Boersma; Stan Maes; Katherine Joekes
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

3.  [Effectiveness of psychological intervention in cardiac rehabilitation].

Authors:  V Antón Menárguez; J M Sempere Ripoll; R Martínez Amorós
Journal:  Semergen       Date:  2018-12-07

Review 4.  Predicting death after acute myocardial infarction.

Authors:  Yulanka Castro-Dominguez; Kumar Dharmarajan; Robert L McNamara
Journal:  Trends Cardiovasc Med       Date:  2017-08-02       Impact factor: 6.677

Review 5.  Depression, alterations in platelet function, and ischemic heart disease.

Authors:  Erica C Bruce; Dominique L Musselman
Journal:  Psychosom Med       Date:  2005 May-Jun       Impact factor: 4.312

6.  The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.

Authors:  Thomas J Carmody; A John Rush; Ira Bernstein; Diane Warden; Stephen Brannan; Daniel Burnham; Ada Woo; Madhukar H Trivedi
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-12       Impact factor: 4.600

7.  Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction.

Authors:  Thierno Madjou Bah; Sévan Kaloustian; Guy Rousseau; Roger Godbout
Journal:  Behav Pharmacol       Date:  2011-12       Impact factor: 2.293

8.  Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial.

Authors:  James A Blumenthal; Michael A Babyak; Robert M Carney; Marc Huber; Patrice G Saab; Matthew M Burg; David Sheps; Lynda Powell; C Barr Taylor; Peter G Kaufmann
Journal:  Med Sci Sports Exerc       Date:  2004-05       Impact factor: 5.411

9.  Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial.

Authors:  James A Blumenthal; Michael A Babyak; Christopher O'Connor; Steven Keteyian; Joel Landzberg; Jonathan Howlett; William Kraus; Stephen Gottlieb; Gordon Blackburn; Ann Swank; David J Whellan
Journal:  JAMA       Date:  2012-08-01       Impact factor: 56.272

Review 10.  Influence of gut microbiota on neuropsychiatric disorders.

Authors:  María Carmen Cenit; Yolanda Sanz; Pilar Codoñer-Franch
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.